Neurocrine Bioscience buy Deutsche Bank Aktiengesellschaft
Start price
12.12.23
/
50%
€111.60
Target price
12.12.24
€126.18
Performance (%)
7.89%
End price
13.12.24
€120.40
Summary
This prediction ended on 13.12.24 with a price of €120.40. The BUY prediction by Deutsche_Bank_Aktien finished with a performance of 7.89%. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 3.516% | 3.516% | 37.317% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten

